Combined plasmapheresis console and fluid exchanger
Latest Armour Pharmaceutical Company Patents:
- Treatment of immobilized matrices for preparation of pharmaceutical and biological products with anti-microbial agents to remove pyrogen-producing organisms and pyrogens
- Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
- Method of purifying Factor VIII:C
- 8-glycine, des-19-leucine-calcitonin
- (Bis-1,7-S-acetamidomethyl-L-cysteine)salmon calcitonin
Description
FIG. 1 is a front, left side perspective view of a combined plasmapheresis console and fluid exchanger showing our new design;
FIG. 2 is a top plan view thereof;
FIG. 3 is a right side elevational view thereof;
FIG. 4 is a left side elevational view thereof; and
FIG. 5 is a rear elevational view thereof.
Referenced Cited
Patent History
Patent number: D289548
Type: Grant
Filed: Dec 26, 1984
Date of Patent: Apr 28, 1987
Assignee: Armour Pharmaceutical Company (Tuckahoe, NY)
Inventors: Ardis R. Lavender (Chappaqua, NY), Michael Diker (Danbury, CT)
Primary Examiner: A. Hugo Word
Assistant Examiner: Stella M. Reid
Application Number: 6/686,349
Type: Grant
Filed: Dec 26, 1984
Date of Patent: Apr 28, 1987
Assignee: Armour Pharmaceutical Company (Tuckahoe, NY)
Inventors: Ardis R. Lavender (Chappaqua, NY), Michael Diker (Danbury, CT)
Primary Examiner: A. Hugo Word
Assistant Examiner: Stella M. Reid
Application Number: 6/686,349
Classifications
Current U.S. Class:
D24/11;
D24/21